Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 1,375,102 |
|
|||||
| News | - | ||||||
| Day High | 43.76 | Low High |
|||||
| Day Low | 41.93 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ionis Pharmaceuticals Inc | IONS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.12 | -2.60% | 41.97 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 43.54 | 41.93 | 43.76 | 41.97 | 43.09 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,126 | 1,375,102 | $ 42.68 | $ 58,690,313 | - | 34.32 - 54.4446 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:53:19 | 1 | $ 43.54 | USD |
Ionis Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.11B | 145.75M | - | 787.65M | -366.29M | -2.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ionis Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IONS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 41.75 | 43.76 | 41.05 | 42.25 | 768,441 | 0.22 | 0.53% |
| 1 Month | 42.63 | 43.76 | 40.385 | 41.91 | 836,169 | -0.66 | -1.55% |
| 3 Months | 50.02 | 51.98 | 40.385 | 43.91 | 1,086,143 | -8.05 | -16.09% |
| 6 Months | 44.35 | 54.4446 | 40.385 | 47.32 | 1,115,196 | -2.38 | -5.37% |
| 1 Year | 36.20 | 54.4446 | 34.32 | 44.51 | 1,127,262 | 5.77 | 15.94% |
| 3 Years | 42.98 | 54.4446 | 25.04 | 39.60 | 1,113,581 | -1.01 | -2.35% |
| 5 Years | 73.22 | 73.87 | 25.04 | 46.08 | 1,082,789 | -31.25 | -42.68% |
Ionis Pharmaceuticals Description
| Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). |
